Webinar Date: 07/10/2025

ADCs: New Ways to Achieve Precision Conjugation and Scalable Purification

 

October 7th: 6pm CEST | 5pm BST | 12pm EDT | 9am PDT

Although highly successful, the complexities involved in controlling conjugation reactions and purifying the final drug mean it remains especially challenging to manufacture and develop processes for ADC compounds. In this webinar, sponsored by Cytiva, our main speakers and panelists will highlight chemical methods to precisely control stoichiometry and mixing during conjugation, dramatically reducing HMW impurities at the source, simplifying your entire workflow. We will also learn more about scalable purification processes for ADCs, tackling key challenges like free drug removal through integrating protein A capture, cation exchange chromatography, and TFF to boost the robustness of your ADC development and manufacturing processes. 

Key Highlights:

  • Presentation of a flow chemistry method to control conjugation stoichiometry and limit HMW impurities
  • Insight into an integrated large-scale purification process for antibodies and ADCs, including strategies to overcome the critical challenge of free drug removal.
  • Expert panel discussion discussing most pressing issues in ADC process development & manufacturing today

Why Attend:

  • Get practical tips to gain precise control over the conjugation reaction, reducing impurities at the source and significantly simplifying your downstream process.
  • Learn about scalable purification strategies using chromatography and TFF, ultimately saving you time and resources in developing your processes.
  • Opportunity to put your questions to our panel of experts and speakers

Join us for an informative session that will help understand how to achieve superior conjugate quality, reduce purification burdens, and accelerate your ability to develop better manufacturing processes. Register now to secure your spot!

Main Speakers

Christopher Spedaliere

Senior Scientist, Ex-Merck

Cecille Oblette

Scientist, ADC Therapeutics

Beccie Martin

Conjugation Scientist II, ADC Therapeutics

Fireside Chat Panellists

Ernest Kovacs

Senior Director, ADC Conjugation Development, Immunome 

Sara Wichner

Bioconjugation Chemist, Genentech

Fara Lyu

Senior Scientist, AbbVie

Learn More About ADC

What is Beacon ADC?
  • The Most Comprehensive Way to Search the ADC Drug Development Landscape: Unique search ontologies based on ADC drug and trial characteristics
  • Market Leading Approach to ADC Preclinical & Clinical Data Curation: Manual curation of key ADC research and development data points by ADC research scientists
  • Seamlessly Integrate Commercial & Scientific Data all in One Place: Search ADC company and deal data based on their pipeline and technologies.
  • Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
Learn More About Beacon ADC

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more

Menu
Search Icon
Close Icon
Search